- Report
- May 2026
- 450 Pages
Global
From €3636EUR$3,995USD£3,130GBP
- Report
- May 2026
- 500 Pages
Global
From €3636EUR$3,995USD£3,130GBP
- Report
- September 2026
- 568 Pages
Global
From €4092EUR$4,495USD£3,521GBP
- Report
- September 2026
- 685 Pages
Global
From €4092EUR$4,495USD£3,521GBP
- Report
- June 2026
- 593 Pages
Global
From €4092EUR$4,495USD£3,521GBP
- Report
- October 2025
- 377 Pages
Global
From €4506EUR$4,950USD£3,878GBP
- Report
- April 2026
- 200 Pages
Global
From €2722EUR$2,990USD£2,342GBP
- Report
- February 2026
- 120 Pages
Global
From €5416EUR$5,950USD£4,661GBP
- Report
- January 2026
- 120 Pages
Global
From €5416EUR$5,950USD£4,661GBP
- Report
- April 2026
- 135 Pages
Global
From €2730EUR$2,999USD£2,349GBP
€3640EUR$3,999USD£3,133GBP
- Report
- March 2026
- 136 Pages
Global
From €2730EUR$2,999USD£2,349GBP
€3640EUR$3,999USD£3,133GBP
- Report
- September 2026
- 378 Pages
Global
From €5325EUR$5,850USD£4,583GBP
- Report
- May 2026
- 189 Pages
Global
From €4096EUR$4,500USD£3,525GBP
- Report
- May 2026
- 182 Pages
Global
From €4096EUR$4,500USD£3,525GBP
- Report
- November 2025
- 183 Pages
Global
From €4096EUR$4,500USD£3,525GBP
- Report
- November 2025
- 185 Pages
Global
From €4096EUR$4,500USD£3,525GBP
- Report
- September 2026
- 186 Pages
Global
From €3227EUR$3,545USD£2,777GBP
€3586EUR$3,939USD£3,086GBP
- Report
- January 2026
- 185 Pages
Global
From €3227EUR$3,545USD£2,777GBP
€3586EUR$3,939USD£3,086GBP
- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,517GBP
- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,517GBP

The Cancer Genetics market is a subset of the Genomics market, focusing on the study of genetic mutations associated with cancer. This includes the identification of genetic markers that can be used to diagnose, monitor, and treat cancer. It also includes the development of targeted therapies and personalized medicine. Cancer Genetics research is conducted through a variety of methods, such as sequencing, bioinformatics, and gene expression analysis.
The Cancer Genetics market is driven by the increasing prevalence of cancer, advances in technology, and the growing demand for personalized medicine. Additionally, the increasing availability of genomic data and the development of new technologies are expected to drive the market in the future.
Some companies in the Cancer Genetics market include Illumina, Thermo Fisher Scientific, BGI, QIAGEN, and Agilent Technologies. Show Less Read more